多発性骨髄腫治療薬の世界市場レポート 2023年以下を含む:1) 薬剤タイプ別薬剤タイプ別:免疫調節薬、プロテアソーム阻害薬、ヒストン脱アセチル化酵素阻害薬、モノクローナル抗体薬、ステロイド薬2) 治療法別:標的療法、生物学的療法、化学療法3) 販売チャネル別:多発性骨髄腫治療薬の世界市場レポート2023年を含む:標的療法;生物学的療法;化学療法3) 販売チャネル別:病院薬局;小売薬局;オンライン薬局4) エンドユーザー:男性;女性ファイザー社、ジョンソン・エンド・ジョンソン社、メルク社、アッヴィ社Inc.、AbbVie Inc.、Bayer AG.Multiple Myeloma Drugs Global Market Report 2023Including: 1) By Drug Type: Immunomodulatory Drugs; Proteasome Inhibitors; Histone Deacetylase Inhibitors; Monoclonal Antibody Drugs; Steroids2) By Therapy: Targeted Therapy; Biologic Therapy; Chemotherapy3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies4) By End-User: Men; WomenCovering: Pfizer Inc.; Johnson & Johnson Pvt. Ltd; Merck & Co. Inc.; AbbVie Inc.; Bayer AG. The Business Research Companyの多発性骨髄腫治療薬の世界市場レポート2023は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。 このレポートは力強い成長を... もっと見る
サマリーThe Business Research Companyの多発性骨髄腫治療薬の世界市場レポート2023は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。このレポートは力強い成長を遂げている多発性骨髄腫治療薬市場に焦点を当てています。今後10年間およびそれ以降の市場を形成するトレンドのガイドを提供します。 購入の理由 - 50以上の地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。 - 市場がCOVID-19の影響をどのように受けてきたか、またウイルスの影響が和らぐにつれて市場がどのように対応しているかを理解する。 - ロシア・ウクライナ戦争が農業、エネルギー、鉱物資源供給に与える影響と、市場への直接的・間接的影響を評価する。 - 世界的な高インフレが市場成長に与える影響を測定する。 - 現地のデータと分析に基づき、地域戦略と国別戦略を策定する。 - 投資の対象となる成長セグメントを特定する。 - 予測データと市場を形成する原動力とトレンドを活用し、競合他社を凌駕する。 - 最新の市場シェアに基づいて顧客を理解する。 - 主要な競合他社に対する業績のベンチマーク - 信頼性の高い高品質のデータと分析により、社内外でのプレゼンテーションをサポートするのに適しています。 - レポートは最新データに更新され、データ抽出と分析が簡単にできるExcelデータシートとともに、ご注文から3~5営業日以内にお届けします。 - レポートの全データは、エクセルのダッシュボード形式でも納品されます。 説明 多発性骨髄腫治療薬の最大かつ最速の成長市場はどこか?経済全体、人口動態、他の類似市場との関連は?今後どのような力が市場を形成していくのか?ビジネスリサーチ社の多発性骨髄腫治療薬世界市場レポートでは、これらすべての疑問やその他多くの疑問にお答えします。 本レポートでは、市場の特徴、規模および成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、動向、戦略を網羅しています。地域別に市場の過去および予測市場成長を追跡します。 調査範囲 対象市場:1) 薬剤タイプ別薬物タイプ別:免疫調節薬;プロテアソーム阻害薬;ヒストン脱アセチル化酵素阻害薬;モノクローナル抗体薬;ステロイド;その他の薬物タイプ 2) 治療法別標的療法;生物学的療法;化学療法;その他の療法 3) 販売チャネル別病院薬局;小売薬局;オンライン薬局;その他の流通チャネル 4) エンドユーザー別:男性;女性 言及された企業ファイザー;ジョンソン・エンド・ジョンソン;メルク社;アッヴィ社;バイエル社Inc.、AbbVie Inc.、Bayer AG. 国名オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、英国、米国、カナダ、イタリア、スペイン 地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ 時系列:過去5年間および過去10年間の予測。 データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、 データ区分:国別・地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。 ソーシングと参照:本レポート中のデータおよび分析は、エンドノートを使用しています。 納品形式PDF、Word、Excel データダッシュボード。 目次1. Executive Summary2. Multiple Myeloma Drugs Market Characteristics 3. Multiple Myeloma Drugs Market Trends And Strategies 4. Multiple Myeloma Drugs Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Multiple Myeloma Drugs Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Multiple Myeloma Drugs Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Multiple Myeloma Drugs Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Multiple Myeloma Drugs Market Segmentation 6.1. Global Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Immunomodulatory Drugs Proteasome Inhibitors Histone Deacetylase Inhibitors Monoclonal Antibody Drugs Steroids Other Drug Types 6.2. Global Multiple Myeloma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Targeted Therapy Biologic Therapy Chemotherapy Other Therapies 6.3. Global Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Hospital Pharmacies Retail Pharmacies Online Pharmacies Other Distribution Channels 6.4. Global Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Men Women 7. Multiple Myeloma Drugs Market Regional And Country Analysis 7.1. Global Multiple Myeloma Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Multiple Myeloma Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Multiple Myeloma Drugs Market 8.1. Asia-Pacific Multiple Myeloma Drugs Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Multiple Myeloma Drugs Market 9.1. China Multiple Myeloma Drugs Market Overview 9.2. China Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Multiple Myeloma Drugs Market 10.1. India Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Multiple Myeloma Drugs Market 11.1. Japan Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Multiple Myeloma Drugs Market 12.1. Australia Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Multiple Myeloma Drugs Market 13.1. Indonesia Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Multiple Myeloma Drugs Market 14.1. South Korea Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Multiple Myeloma Drugs Market 15.1. Western Europe Multiple Myeloma Drugs Market Overview 15.2. Western Europe Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Multiple Myeloma Drugs Market 16.1. UK Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Multiple Myeloma Drugs Market 17.1. Germany Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Multiple Myeloma Drugs Market 18.1. France Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Multiple Myeloma Drugs Market 19.1. Italy Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Multiple Myeloma Drugs Market 20.1. Spain Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Multiple Myeloma Drugs Market 21.1. Eastern Europe Multiple Myeloma Drugs Market Overview 21.2. Eastern Europe Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Multiple Myeloma Drugs Market 22.1. Russia Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Multiple Myeloma Drugs Market 23.1. North America Multiple Myeloma Drugs Market Overview 23.2. North America Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Multiple Myeloma Drugs Market 24.1. USA Multiple Myeloma Drugs Market Overview 24.2. USA Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Multiple Myeloma Drugs Market 25.1. Canada Multiple Myeloma Drugs Market Overview 25.2. Canada Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Multiple Myeloma Drugs Market 26.1. South America Multiple Myeloma Drugs Market Overview 26.2. South America Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Multiple Myeloma Drugs Market 27.1. Brazil Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Multiple Myeloma Drugs Market 28.1. Middle East Multiple Myeloma Drugs Market Overview 28.2. Middle East Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Multiple Myeloma Drugs Market 29.1. Africa Multiple Myeloma Drugs Market Overview 29.2. Africa Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Multiple Myeloma Drugs Market Competitive Landscape And Company Profiles 30.1. Multiple Myeloma Drugs Market Competitive Landscape 30.2. Multiple Myeloma Drugs Market Company Profiles 30.2.1. Pfizer Inc. 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. Johnson & Johnson Pvt. Ltd 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. Merck & Co. Inc. 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. AbbVie Inc. 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. Bayer AG. 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Multiple Myeloma Drugs Market Other Major And Innovative Companies 31.1. Roche Holding AG 31.2. Novartis AG 31.3. Sanofi S.A. 31.4. Bristol-Myers Squibb Company 31.5. GlaxoSmithKline Plc 31.6. Takeda Pharmaceutical Company Limited 31.7. Eli Lilly and Company 31.8. Kite Pharma Inc 31.9. Amgen Inc. 31.10. AstraZeneca plc 31.11. Teva Pharmaceutical Industries Ltd. 31.12. Regeneron Pharmaceuticals Inc. 31.13. Daiichi Sankyo Company 31.14. Daiichi Sankyo Co. Ltd. 31.15. Lonza Group AG 32. Global Multiple Myeloma Drugs Market Competitive Benchmarking 33. Global Multiple Myeloma Drugs Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Multiple Myeloma Drugs Market 35. Multiple Myeloma Drugs Market Future Outlook and Potential Analysis 35.1 Multiple Myeloma Drugs Market In 2027 - Countries Offering Most New Opportunities 35.2 Multiple Myeloma Drugs Market In 2027 - Segments Offering Most New Opportunities 35.3 Multiple Myeloma Drugs Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
SummaryMultiple Myeloma Drugs Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. Table of Contents1. Executive Summary2. Multiple Myeloma Drugs Market Characteristics 3. Multiple Myeloma Drugs Market Trends And Strategies 4. Multiple Myeloma Drugs Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Multiple Myeloma Drugs Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Multiple Myeloma Drugs Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Multiple Myeloma Drugs Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Multiple Myeloma Drugs Market Segmentation 6.1. Global Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Immunomodulatory Drugs Proteasome Inhibitors Histone Deacetylase Inhibitors Monoclonal Antibody Drugs Steroids Other Drug Types 6.2. Global Multiple Myeloma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Targeted Therapy Biologic Therapy Chemotherapy Other Therapies 6.3. Global Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Hospital Pharmacies Retail Pharmacies Online Pharmacies Other Distribution Channels 6.4. Global Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Men Women 7. Multiple Myeloma Drugs Market Regional And Country Analysis 7.1. Global Multiple Myeloma Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Multiple Myeloma Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Multiple Myeloma Drugs Market 8.1. Asia-Pacific Multiple Myeloma Drugs Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Multiple Myeloma Drugs Market 9.1. China Multiple Myeloma Drugs Market Overview 9.2. China Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Multiple Myeloma Drugs Market 10.1. India Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Multiple Myeloma Drugs Market 11.1. Japan Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Multiple Myeloma Drugs Market 12.1. Australia Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Multiple Myeloma Drugs Market 13.1. Indonesia Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Multiple Myeloma Drugs Market 14.1. South Korea Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Multiple Myeloma Drugs Market 15.1. Western Europe Multiple Myeloma Drugs Market Overview 15.2. Western Europe Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Multiple Myeloma Drugs Market 16.1. UK Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Multiple Myeloma Drugs Market 17.1. Germany Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Multiple Myeloma Drugs Market 18.1. France Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Multiple Myeloma Drugs Market 19.1. Italy Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Multiple Myeloma Drugs Market 20.1. Spain Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Multiple Myeloma Drugs Market 21.1. Eastern Europe Multiple Myeloma Drugs Market Overview 21.2. Eastern Europe Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Multiple Myeloma Drugs Market 22.1. Russia Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Multiple Myeloma Drugs Market 23.1. North America Multiple Myeloma Drugs Market Overview 23.2. North America Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Multiple Myeloma Drugs Market 24.1. USA Multiple Myeloma Drugs Market Overview 24.2. USA Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Multiple Myeloma Drugs Market 25.1. Canada Multiple Myeloma Drugs Market Overview 25.2. Canada Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Multiple Myeloma Drugs Market 26.1. South America Multiple Myeloma Drugs Market Overview 26.2. South America Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Multiple Myeloma Drugs Market 27.1. Brazil Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Multiple Myeloma Drugs Market 28.1. Middle East Multiple Myeloma Drugs Market Overview 28.2. Middle East Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Multiple Myeloma Drugs Market 29.1. Africa Multiple Myeloma Drugs Market Overview 29.2. Africa Multiple Myeloma Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Multiple Myeloma Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Multiple Myeloma Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Multiple Myeloma Drugs Market Competitive Landscape And Company Profiles 30.1. Multiple Myeloma Drugs Market Competitive Landscape 30.2. Multiple Myeloma Drugs Market Company Profiles 30.2.1. Pfizer Inc. 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. Johnson & Johnson Pvt. Ltd 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. Merck & Co. Inc. 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. AbbVie Inc. 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. Bayer AG. 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Multiple Myeloma Drugs Market Other Major And Innovative Companies 31.1. Roche Holding AG 31.2. Novartis AG 31.3. Sanofi S.A. 31.4. Bristol-Myers Squibb Company 31.5. GlaxoSmithKline Plc 31.6. Takeda Pharmaceutical Company Limited 31.7. Eli Lilly and Company 31.8. Kite Pharma Inc 31.9. Amgen Inc. 31.10. AstraZeneca plc 31.11. Teva Pharmaceutical Industries Ltd. 31.12. Regeneron Pharmaceuticals Inc. 31.13. Daiichi Sankyo Company 31.14. Daiichi Sankyo Co. Ltd. 31.15. Lonza Group AG 32. Global Multiple Myeloma Drugs Market Competitive Benchmarking 33. Global Multiple Myeloma Drugs Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Multiple Myeloma Drugs Market 35. Multiple Myeloma Drugs Market Future Outlook and Potential Analysis 35.1 Multiple Myeloma Drugs Market In 2027 - Countries Offering Most New Opportunities 35.2 Multiple Myeloma Drugs Market In 2027 - Segments Offering Most New Opportunities 35.3 Multiple Myeloma Drugs Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
The Business Research Company (TBRC) 社の最新刊レポート
本レポートと同じKEY WORD(distribution channel)の最新刊レポート
よくあるご質問The Business Research Company (TBRC)社はどのような調査会社ですか?The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/12 10:26 154.83 円 165.45 円 201.96 円 |